Hepatocellular Carcinoma: Western Experience Image-Guided Interventions in Oncology pp 81-118 Maguire T.J., Shreenivas A., Rilling W.S. (2020) Hepatocellular Carcinoma: Western Experience. In: Georgiades C., Kim H. (eds) Image-Guided Interventions in Oncology. Springer, Cham. https://doi.org/10.1007/978-3-030-48767-6_6
Date
07/29/2020Abstract
The etiology and management of hepatocellular carcinoma varies greatly across the United States and the world at large. Guidelines are continuously evolving, and there is currently no single standard of care for American patients with advanced hepatocellular carcinoma. Technical advances have made even complex minimally invasive therapies more feasible and widely available, while a variety of novel systemic therapies continue to be developed. Interventional Oncologists are increasing able to provide curative-intent treatments for early-stage hepatocellular carcinoma patients. These developments have also contributed to improved outcomes and innovative, personalized treatment paradigms for patients with later stage disease.
The following is a condensed review of the contemporary diagnosis and clinical management of hepatocellular carcinoma, with an emphasis on the current standards of care in the United States. Integrative, multidisciplinary care plays a large role in the continued effort to reduce the morbidity and mortality associated with this debilitating malignancy. For further reference, the current treatment guidelines from the American Association for the Study of Liver Diseases (AASLD) are cited with other Key Readings at the conclusion of the chapter.
Author List
Thaddeus J. Maguire, Aditya Shreenivas, William S. RillingAuthor
Aditya Shreenivas MD Assistant Professor in the Medicine department at Medical College of WisconsinView Online